Wells Fargo & Company Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $207.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target lifted by Wells Fargo & Company from $161.00 to $207.00 in a research note released on Tuesday, Benzinga reports. They currently have an equal weight rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on ALNY. Chardan Capital reissued a […]
More Stories
Bessent Warns China, Others Not to Test US Resolve on Iran Sanctions
By Andrew Moran and Emel Akan Bessent, at an Aug. 24 news conference, unveiled the contours of the administration’s sweeping...
Gold Prices Surge to Highest Level in Over 3 Months
By Naveen Athrappully Gold prices are trading at their highest level in more than three months on Monday, amid continued...
Treasury, IRS Propose Rules on Trump Account Investments
By Naveen Athrappully The Department of the Treasury and the IRS have issued proposed regulations clarifying which investments may be...
Iryna Zarutska’s Family Sues City of Charlotte Over Fatal Rail Stabbing, Blaming Security Failures
By Owen Evans The family of 23-year-old Ukrainian refugee Iryna Zarutska, who was stabbed to death in North Carolina, has...
IndyCar Race Caps Summer Events for America’s 250th Birthday
By Travis Gillmore WASHINGTON—More than 100,000 spectators lined the streets to witness history as drivers raced by national monuments on...
Zelenskyy Rejects Calls for Wartime Elections in Ukraine
By Tom Gantert Ukrainian President Volodymyr Zelenskyy said holding elections during the war with Russia would “destroy the country,” in...